This study is testing a new imaging system called MRg-NIRS (Magnetic Resonance-guided Near-infrared Spectroscopy) to see if it can help detect breast cancer. Researchers want to find out if adding MRg-NIRS to standard breast MRI (magnetic resonance imaging) can improve how doctors manage breast cancer. They will test this system on 20 women who have been recently diagnosed with breast cancer. To join, you must be a woman between 18 and 83 years old with a breast cancer diagnosis, and if you're having pre-surgical planning, your tumor must be 2.0 cm or less. The main goal is to see if the MRg-NIRS system works as well as or better than current MRI methods.

Study design

This is an interventional study involving 20 women. It is designed to evaluate the MRg-NIRS system with and without contrast.

What's involved

Participants will undergo an MRg-NIRS exam, which will measure optical sensitivity for up to one hour on the day of their MRI.

Compensation

Not stated in the trial record.

Follow-up

Optical sensitivity is measured at up to one hour on the day of the MRI.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.